Here is a listing of key offers reported throughout sectors this week:
Ocular Therapeutix (NASDAQ:OCUL) rose 6% amid takeover hypothesis. There’s hypothesis {that a} French pharmaceutical firm is circling Ocular Therapeutix (NASDAQ:OCUL), based on merchants, who cited a
